A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
ARCE Therapeutics, Inc.
Children's Hospital Medical Center, Cincinnati
Thomas Jefferson University
University of Rochester